Colorado Springs Neurological Associates is one of the largest and longest-standing neuroscience medical practices in southern Colorado.
Our aim is to deliver the highest standard of neurological care – the same level of care we would want for ourselves or our loved ones. The Center has a dedicated clinical research institute with experienced principal investigators and full-time research staff.
Collectively, our investigators have vast experience conducting phase II through phase IV clinical trials in a broad range of neurologic diseases affecting adults and children.
-
Age 18-75
-
Diagnosis of focal epilepsy for 2 years or more
-
Have had at least 2 focal seizures per month during the past 3 months
-
Are taking a stable dose of up to 3 daily anti-seizure medications, not including rescue (as-needed) medications
- Contact: Research@csneuro.com
-
Age 18+
-
Confirmed MG diagnosis
-
Eligible for treatment with efgartigimod
EMVIGORATE Study
A Phase 3, randomized, double-blinded study comparing intravenous empasiprubart vs IVIG in adults with CIDP.
Eligibility Criteria:
- Age 18+
- Not pregnant or trying to become pregnant
- Diagnosed with CIDP
Learn More:
A Phase 3, randomized, placebo-controlled study evaluating empasiprubart IV in adults with CIDP.
Eligibility Criteria:
- Age 18+
- Not pregnant or trying to become pregnant
- Diagnosed with CIDP
Learn More:
ENABLE Study
A longitudinal registry study evaluating real-world experience with BRIUMVI® (ublituximab-xiiy).
Eligibility Criteria:
- Age 18+
- Diagnosis of relapsing MS
- No active infection
- No prior BRIUMVI treatment
Learn More:
- https://clinicaltrials.gov/study/NCT06433752
- Contact: Research@csneuro.com or ask your provider
- Flyer
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders (Project 2): Research participants aged 18-35 needed!
- We are recruiting healthy volunteers AND adults with a diagnosis of concussion/mTBI in the last 12 months.
- We are looking to find the best way to test eye teaming and focusing problems occurring after mild traumatic brain injury (mTBI).
- One study visit for mTBI participants and two study visits for controls. Visits involve answering questions about your vision and undergoing a series of vision tests.
Learn More:
- To learn more about the study, please contact the Research Department at Research@csneuro.com
- Flyer